Solana Co — Director's Dealing 2019

Apr 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2019-04-05

Reporting Person: Deschamps Philippe (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-05	Class A Common Stock	M	5018	$5.60	Acquired	15995	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-05	Warrant (Right to Buy)	$5.60	M	5018	Disposed	2019-04-18	Class A Common Stock (5018)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	666911	Indirect

Footnotes

F1: These securities are directly held by Deschamps Global Healthcare Commercialization LLC (the "LLC") and includes shares previously held directly by MPJ Healthcare, LLC ("MPJ"). The Reporting Person is a member of MPJ and is the sole member of the LLC.

F2: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00=CAD$1.3387 on April 5, 2019. The exercise price of the Warrant was CAD $7.50.